Core B - Nanomaterials

$225,301P20FY2015GMNIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications & trials

Paper 38093839 Paper 35073053 Paper 34049358 Paper 33819812 Paper 33455340 Paper 32877763 Paper 32863236 Paper 32724116 Paper 32656444 Paper 32445658 Paper 32361681 Paper 32222469 Paper 32010667 Paper 31820350 Paper 31728622 Paper 31695100 Paper 31474482 Paper 31400571 Paper 31158752 Paper 31150251 Paper 31121280 Paper 31077762 Paper 30956167 Paper 30881591 Paper 30683666 Paper 30663697 Paper 30662086 Paper 30605770 Paper 30588791 Paper 30573187 Paper 30550805 Paper 30483886 Paper 30421721 Paper 30245386 Paper 30182093 Paper 29993232 Paper 29985361 Paper 29972648 Paper 29942988 Paper 29890268 Paper 29799600 Paper 29601972 Paper 29498244 Paper 29370088 Paper 29354263 Paper 29325740 Paper 29286255 Paper 29279107 Paper 29269334 Paper 29210522 Paper 29113120 Paper 29097944 Paper 28960168 Paper 28870832 Paper 28867395 Paper 28615298 Paper 28520509 Paper 28509362 Paper 28319404 Paper 28263073 Paper 28196872 Paper 28185940 Paper 28085088 Paper 28058292 Paper 27989854 Paper 27939052 Paper 27709840 Paper 27661393 Paper 27372424 Paper 27222845 Paper 27060278 Paper 26859680 Paper 26855082 Paper 26751774 Paper 26697135 Paper 26692492 Paper 26612356 Paper 26571000 Paper 26496777 Paper 26480472 Paper 26407671 Paper 26381902 Paper 26318196 Paper 26316178 Paper 26302836 Paper 26298393 Paper 26111481 Paper 26093094 Paper 26082630 Paper 25906442 Paper 25773720 Paper 25732665 Paper 25684778 Paper 25660204 Paper 25652894 Paper 25645958 Paper 25634251 Paper 25624117 Paper 25565816 Paper 25468272

Abstract

The proposed Core B will serve three primary functions. First, it will develop nanoscale materials for drug delivery for each of the projects. This will include new nanocarriers for drug, radiopharmaceutics and protein delivery, and include cleavable multi-block HPMA copolymers (Project 6), targeted HPMA copolymer-drug conjugates (Project 9), and protein nanocarriers (Project 7, 8, and 10). Second, the Core will assist the Center's scientists in comprehensive and in-depth characterization of the nanomaterials. The combined characterization techniques include the following: dynamic light scattering; zeta-potential measurements; analytical ultracentrifugation; surface plasmon resonance; atomic force microscopy; transmission electron microscopy; inductively coupled plasma mass spectroscopy, and fluorescence spectroscopy. Third, the Core will evaluate safety of all new synthesized nanomaterials using the respective cell lines and animal models, and the Core will provide all investigators with controlled and standardized materials for biological use.

View original record on NIH RePORTER →